Skip to main content
logo
Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India flag India · Delayed Price · Currency is INR
364.55
+0.60 (0.16%)
Jul 21, 2026, 3:29 PM IST

Gujarat Themis Biosyn Revenue

In the fiscal year ending March 31, 2026, Gujarat Themis Biosyn had annual revenue of 1.66B INR with 9.96% growth. Gujarat Themis Biosyn had revenue of 442.33M in the quarter ending March 31, 2026, with 17.22% growth.

Revenue
1.66B
Revenue Growth
+9.96%
P/S Ratio
23.95
Revenue / Employee
7.50M
Employees
221
Market Cap
39.71B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.66B150.23M9.96%
Mar 31, 20251.51B-190.22M-11.20%
Mar 31, 20241.70B214.37M14.45%
Mar 31, 20231.48B335.31M29.19%
Mar 31, 20221.15B242.91M26.82%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Indoco Remedies18.45B
Aarti Pharmalabs18.19B
Innova Captab16.30B
Solara Active Pharma Sciences13.69B
Windlas Biotech9.04B
Orchid Pharma8.11B
RPG Life Sciences7.08B
Ind-Swift Laboratories6.41B
Revenue Rankings

Gujarat Themis Biosyn News

More News